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INTRODUCTION 
Postopertive pain is one of the most feared problem among 
patients coming for surgery.  
International association for study of pain defines pain 
as “an unpleasant sensory and emotional experience 
associated with actual or potential tissue damage or described 
in terms of such damage”.  
Surgical pain mechanism 
Post operative pain is caused by  
1) Inflammation from tissue trauma caused by surgical 
incision, dissection of tissues and burns due to use of 
cautery and  
2) Direct nerve injury caused by nerve transection, 
stretching or compression. 
Tissue trauma causes release of local inflammatory 
mediators. Producing augmented sensitivity to stimuli in the 
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area surrounding the injury (ie) hyperalgesia or causes 
misperception of pain to non-noxious stimuli (ie) Allodynia. 
 
 
Pain following hysterectomy is often multifactorial produced 
from difference sources. Pain arises from incisional site, deeper 
visceral structures and pain on movement such as during straining, 
coughing or mobilization may be severe. Abdominal procedure is 
more invasive than vaginal procedure and produces more pain. 
Proper management of postoperative pain leads to early 
mobilization short hospital stay, less hospital costs and increased 
patient satisfaction. Pain control regimens must be tailored 
according to the needs of individual patient taking into account 
their age, medical condition, physical condition, level of anxiety, 
surgical procedure and response to agents administered. 
ACUTE EFFECTS OF POSTOPERATIVE PAIN.   
 Emotional and physical suffering of the patient   
 sleep disturbance. 
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 Respiratory system: Decreases lung volumes, impairs cough, 
sputum retention, infection, atelectasis. 
 Cardiovascular system: Tachycardia, Hypertension, increases 
oxygen consumption, myocardial ischemia, deep venous 
thrombosis. 
 Gastrointestinal system: Reduces bowel motility. 
 Genitourinary system: Urinary retention. 
 Endocrine System: Increases catabolic hormones, increases 
blood glucose, causes sodium and water retention. 
 Central nervous system: anxiety 
 Immunologic impairment, infection, delayed wound healing 
 
CHRONIC EFFECTS OF POSTOPERATIVE PAIN: 
 Risk factor for development of chronic pain. 
 Risk of behavioural changes mainly in children. 
 Delay in long term recovery. 
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GOALS OF POSTOPERATIVE PAIN MANAGEMENT 
 To minimize the physiological stress response caused by pain. 
 To optimize patient recovery and reduce hospital length of 
study. 
 To minimize the development of chronic pain syndromes 
related to surgical procedures. 
Major goal of postoperative pain management is to minimize 
the dose of medication, to lessen the side effects and providing 
adequate analgesia. This can be achieved by multimodal approach 
to pain management. 
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AIM OF THE STUDY 
Aim of the study is to evaluate whether gabapentin when   
given oral preoperatively at a dose of 300mg has an effect on 
postoperative pain and analgesic requirement in patients 
undergoing total abdominal hysterectomy under spinal anaesthesia. 
The study also evaluates the side effects associated with 
administration of gabapentin.  
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         PATHOPHYSIOLOGY OF NOCICEPTION                                      
                   Nociception is defined as the neural response to 
painful stimuli.               
The physiological processes involved in nociception are                   
• Transduction 
• Transmission 
• Perception 
• Modulation  
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   Picture demonstrating physiological process of nociception 
TRANSDUCTION: 
                 Transduction is the process by which a noxious 
stimuli produced by tissue injury gets converted into electrical 
signals. This process occurs in nociceptors. Free nerve endings of 
unmyelinated C fibres and myelinated Aδ fibres act as nociceptors .   
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There are different types of nociceptors:                                                                                    
• mechanoreceptors : They respond to pinch and 
pinprick.            
• Silent nociceptors : Respond only during inflammation 
• Polymodal nociceptors: respond to pain temperature and 
pressure. 
                Nociceptors do not have the property to get 
adapted to noxious stimuli. This results in continued excitation 
leading to reduced threshold of nociceptors which is termed as 
sensitization of nociceptors. 
                Primary afferent neurons of nociception are of 
pseudounipolar variety. They have their cell bodies in dorsal root 
ganglia, with a peripheral terminal which ends as nociceptors and a 
central terminal which synapses with second order neurons in the 
dorsal horn of spinal cord. Neurotransmitters produced and released 
by these neurons in response to stimuli is similar at both peripheral 
and central terminals. 
              The noxious stimuli can be chemical, mechanical or 
thermal. Noxious stimulation leads to release of following chemical 
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mediators from damaged tissues: prostaglandin bradykinin, 
serotonin, substance P, Potassium, and histamine. These 
neurotransmitters released peripherally leads to sensitization of 
nociceptors to painful stimulus. Exchange of sodium and potassium 
ions at the cell membranes results in action potential and thereby 
pain impulse is generated. 
 
TRANSMISSION: 
                Pain impulse generated by nociceptor is transmitted from 
periphery to the spinal cord and then to thalamus and finally to the 
cerebral cortex. 
              First order neurons are the primary afferent fibres which 
conduct pain impulse from nociceptors to dorsal horn neurons. 
There are two types of primary afferent fibres: 
C fibres and 
Aδ fibres. 
C fibres : They are unmyelinated with small diameter. Their 
conduction velocity is slow : 0.5 – 2m/s. They conduct more than 
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one type of noxious stimuli and hence called as polymodal 
nociceptors. They conduct a diffuse, dull, slow onset pain which is 
called as second pain. They terminate on neurons of lamina I and II 
in dorsal horn of spinal cord. 
Aδ fibres : they are myelinated with large diameter. Their 
conduction velocity is high: 2 – 20m/s. They respond to high 
intensity mechanical stimuli and hence called high threshold 
mechanoreceptors. They conduct a sharp, well localised, fast pain 
called as first pain. They terminate on neurons of lamina I and V in 
dorsal horn of spinal cord. 
               There is a synaptic cleft between the first order neurons 
ending in dorsal horn of spinal cord and the second order neurons. 
The transmission of pain impulse across the cleft is mediated by 
release of excitatory neurotransmitters. They are glutamate, 
substance P, calcitonin gene related peptide, adenosine 
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triphosphate, bradykinin and nitrous oxide.  
 
               Picture depicting Pain pathway 
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               The second order neurons arise from dorsal horn cells of 
spinal cord and conduct impulses from the first order neurons to 
thalamus. Second order neurons are of two types: 
• Nociceptive specific(NS) and 
• Wide dynamic range  neurons(WDR) neurons.  
        
NS neurons respond only to painful stimuli. WDR neurons respond to 
both noxious and non noxious input from Aβ, Aδ, and C fibres. Most of 
the second order neurons cross the midline to opposite side and ascend as 
spinothalamic tract(STT) to relay in thalamus. STT also sends fibres to 
reticular formation, nucleus raphe magnus and periaqueductal gray. STT 
can be divided into lateral and medial tracts. The lateral STT 
(neospinothalamic) terminates in ventral posterolateral nucleus of 
thalamus. It transmits pain and temperature and is responsible for 
emotional perception of pain. 
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               Third order neurons are involved in transmitting the pain 
impulse from thalamus to somatosensory areas I & II in the 
postcentral gyrus and superior wall of the sylvian fissure in the 
cerebral cortex. 
 
PERCEPTION: 
              It is the process by which pain produces conscious 
multidimensional experience. The following areas of cortex are 
involved in pain perception: 
The reticular system : It is involved in mediating a motor response to 
pain. 
Somatosensory cortex: it is responsible for perceiving and interpreting the 
sensation. It is involved in assessing the intensity, type, location of 
sensation and is involved in comparing the sensation with past 
experiences and is responsible for memory of sensation. 
Limbic system: it is responsible for emotional and behavioural responses 
to pain. 
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MODULATION: 
              It is the process by which pain impulses produced are 
either inhibited or facilitated. Modulation occurs peripherally in 
nociceptors and also in spinal cord and supraspinal structures. 
               Stimulation of nociceptors by painful stimuli leads to 
continuous excitation resulting in sensitization of nociceptors. This 
sensitization leads to decreased threshold , decreased response latency, 
increase in frequency of response and continuous excitation even after 
cessation of stimuli. This is called primary hyperalgesia if it occurs in the 
site of injury and if it occurs in uninjured tissues it is called secondary 
hyperalgesia. This response is mediated by bradykinin , histamine and 
leukotrienes 
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Gate control theory of pain: 
               This was hypothesized by Ron Mezlack and Patrick in 
1962. Pain perception is not due to direct activation of nociceptor 
alone rather it is modulated by different neurons. Dorsal horn of 
spinal cord acts as a gate by either inhibiting or allowing 
conduction of pain impulses. Pain signals carried by small nerve 
fibres are allowed to pass through and those carried by large nerve 
fibres are blocked. 
Segmental inhibition: 
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               Glycine and GABA are the inhibitory neurotransmitters 
which mediate segmental inhibition through GABAb  receptor 
activity thereby increasing potassium movement across cell 
membrane. 
Supraspinal inhibition : 
                 Structures involved in supraspinal inhibition are 
periaqueductal gray, reticular formation and nucleus raphe magnus . 
Fibres from these sites act presynaptically on first order neurons 
and postsynaptically on second order neurons. In this process 
monoamines like nor-adrenaline and serotonin act as 
neurotransmitters which acts on spinal inhibitory interneurons to 
produce analgesia.   
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                          MULTIMODAL ANALGESIA 
 
Kehlet and Dahl were the first to describe the concept of combining 
multiple analgesic technique in 1993, to improve outcome 
following surgery. 
This concept was introduced to maximize analgesic benefits and to 
reduce the incidence of opioid- related adverse effects. Multimodal 
analgesia is achieved by combing different analgesics that act by 
different mechanisms at different sites in the nervous system, so 
that adequate analgesia is attained with lower doses and reduced 
incidence of side effects. 
To attain maximum benefit pain management must be initiated in 
the preoperative period, continued intraoperatively and in the post 
operative period. 
It is effective in patients who are at risk of side effects for large 
doses of opioids.  
(ie) elderly, obstructive sleep apnea, chronic pain patients.  
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BENEFITS 
Provides effective analgesia due to synergistic action. 
Less side effects due to lower dosage of drug used. 
Faster recovery 
MODES OF INTERVENTION 
 
 
Reducing Nociceptive input 
1.Peripherally acting drugs 
19 
 
   A) Local anaesthetics: Local infiltration, Nerve Blocks, Spinal/            
Epidural blockade 
  B) NSAIDS:Cycloxygenase inhibitors 
  C) Glucocorticoids 
2.Drugs acting in spinal cord 
  A) Opiates 
  B) NSAIDS 
  C) NMDA receptor antagonist 
  D) Gabapentinoids: gabapentin, pregabalin 
Drugs acting centrally: 
   A) Opiates  
   B) Acetaminophen  
Drugs acting on descending pain pathway: 
   A) Tramadol 
   B) Alpha 2 agonists 
   C) 5 HT3 antagonists 
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PRE-EMPTIVE ANALGESIA 
The concept of pain prevention was first introduced by crile in 1913 
and later developed by wall and woolf. 
Pre emptive analgesia is defined as analgesic intervention given 
before noxious stimulus to attenuate or block sensitisation of 
central and peripheral pain patheway, which amplifies post 
operative pain. 
GOALS 
Prevents pain related pathologic modulation of central nervous 
system. 
Decreases acute pain after tissue injury. 
Inhibits persistence of post operative pain and development of 
chronic pain. 
Effective preemptive analgesia uses multiple pharmacologic agents 
to reduce nociceptor activation by blocking or decreasing receptor 
activation and by inhibiting the production or activation of pain 
neurotransmitters. 
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CONCEPT: 
Pain sensation from damaged tissues initiates a cascade of 
alterations in somatosensory system leading to increased 
responsiveness of both central and peripheral neurons. Because of 
these alterations, response to subsequent stimuli is increased thus 
amplifying pain. 
In preemptive analgesia, antinociceptive treatment is started before 
and is operational during the surgical procedure so that the 
physiological consequences of nociceptive transmission are 
reduced. Because of this protective effect on nociceptive pathways, 
preemptive analgesia is more effective than analgesic treatment 
initiated after surgery. Thereby preemptive analgesia reduces 
immediate post operative pain and prevents the development of 
chronic pain. 
SCIENTIFIC RATIONALE 
Tissue damage is detected by free nerve endings of peripheral 
nerves (first order neurons) called nociceptors. They act as 
transducers converting mechanical, chemical and thermal injury 
22 
 
into electrical signals, which are then transmitted to dorsal horn 
neurons (second order neurons) in spinal cord. Nociceptors are of 
different types. Myelinated A delta nociceptors conduct rapid, 
sharp and well localized pain called first pain. Unmyelinated C 
nociceptors conduct duller, slower onset and poorly localized pain 
called second pain. 
Dorsal horn contains two groups of neurons. Nociceptive specific 
(NS) neurons respond only to noxious stimuli from A delta and C 
nociceptors. Wide dynamic range (WDR) neurons respond to both 
noxious stimuli and non-noxious stimuli from Aβ fibres (ie touch). 
Activity of WDR neurons depend on excitatory and inhibitory input 
from nociceptive and non-nociceptive peripheral nerve fibres and 
descending inputs from supraspinal sites. 
Tissues damage produces local inflammation by release of pain 
promoting substances (ie) substance P, prostaglandin, serotonin, 
bradykinin and histamine. They lead to peripheral sensitization of 
nociceptors which produce altered transduction and increased 
conduction of noxious impulses to CNS. Conduction of noxious 
stimuli from nociceptors to dorsal horn neurons (NS & WDR) 
results in altered responsiveness of these neurons. Stimuli from A 
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delta & C fibres are amplified (ie) Hyperalgesia and stimulus from 
Aβ fibres are misinterpreted (ie) Allodynia. This is central 
sensitization. 
Preemptive analgesia helps to prevent the neurological and 
biochemical consequences of noxious input to central nervous 
system.  
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  POSTOPERATIVE PAIN ASSESSMENT METHODS 
It is very important to assess the degree of pain experienced by the 
patient in the postoperative period. Pain assessment is considered 
as an important vital sign in postoperative patients. It must be done 
periodically. 
          Postoperative pain assessment involves preoperative 
education of the patient about pain following surgery. This 
preoperative education helps the patient to gain knowledge which 
alleviates the fear about pain and helps to reduce anxiety about 
pain. It also helps them to develop a positive approach towards pain 
thereby improving satisfaction of the patient. 
     Postoperative pain assessment helps us to quantitate the 
intensity of pain , helps us to formulate analgesic regimen and also 
helps to assess the response to treatment given. There are a number 
of pain assessment methods. These methods must be simple and 
easily understandable by the patients. 
      Commonly used pain scales are 
• Visual analogue scale 
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• Numerical rating scale 
• Verbal rating scale 
• Wong baker faces rating scale 
Visual analogue scale: 
       This scale is simple to use. It has a ten centimetre line with left 
end marked as no pain and right end marked as severe pain ever 
experienced. Patient is asked to mark a point on the line which 
corresponds to their pain intensity. Distance in centimeters 
recorded from left end of the line to upto patients mark is 
considered as the pain score. This scale is not useful in children, 
visually impaired persons and in those with cognitive impairment. 
 
Numerical rating scale: 
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       This scale closely resembles visual analogue scale. It consists 
of a ten centimetre line with left end marked as zero corresponding 
to no pain and, right end marked as ten corresponding to worst pain 
with numbers marked inbetween from one to nine. Thus it has 
eleven points on the scale. Patients are asked to point out a number 
on the scale which corresponds to their pain score 
.  
Verbal rating scale: 
      Here the patients were asked to express their pain verbally as 
no pain, mild pain, moderate pain and severe pain. Small changes in 
pain intensity cannot be made out in this scale. 
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Wong baker faces rating scale:  
        This scale is useful in persons who cannot communicate  
properly and in children less than seven years of age. 
Wong-Baker FACES Pain Rating Scale 
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GABAPENTIN 
Gabapetin is a second generation anticonvulsant drug. Introduced in 
1993 for treatment of refractory partial seizures. Later it was found 
to be effective in treating chronic pain conditions like post herpetic 
neuralgia, diabetic neuropathy, trigeminal neuralgia, HIV- related 
neuropathy, complex regional pain syndromes, inflammatory pain 
and malignant pain. Recently its use has been extended for 
management of postoperative pain. 
CHEMISTRY 
Gabapentin, 1-(aminomethyl) cyclohexane acetic acid a structural 
analogue of Gamma amino butyric acid (GABA), an inhibitory 
neurotransmitter. It is a white crystalline soild. Highly charged at 
physiological PH.  Freely soluble in water. 
Molecular formula: C9 H17 NO2 
Molecular weight: 171.24 
P Ka1: 3.7 
PKa2: 10.7 
High performance liquid chromatography and gas chromatography 
are used for drug assay in urine and plasma. 
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PHARMACOKINETICS 
Oral bioavailability 
Absorption of gabapentin is not dose dependant, because of a 
saturable L-aminoacid transport mechanism in the intestine. Hence 
oral bioavailability varies inversely with dosage. After a single 
dose of 300 and 600mg, bioavailability was 60% and 40% 
respectively. 
DISTRIBUTION 
Extensively distributed in human tissues and fluid after 
administration. Volume f distribution is 0.6-0.8l/Kg. Concentration 
in adipose tissue is low because it is highly ionized at physiological 
PH. Less that 30% is bound to plasma proteins. Concentration in 
cerebrospinal fluid is 5-35% of those in plasma and in brain tissue 
it is 80% of those in plasma. After oral intake, peak plasma 
concentration is reached in 2-3 hours. 
METABOLISM 
Gabapentin is not metabolized in human body. Does not induce 
hepatic microsomal enzymes. 
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ELIMINATION 
It gets eliminated unchanged in urine and unabsorbed drug is 
excreted in faces and renal clearance is related in a linear manner to 
creatinine clearance. Elimination half-life is 5-7 hours in patients 
with normal renal function and is unchanged by dose. It can be 
removed by haemodialysis. 
DRUG INTERACTION 
Cimetidine, a H2 receptor blocker decreases renal clearance when 
given concurrently. 
Antacids reduce the bioavailability of gabapetin when given 
concurrently. 
 
 
SPECIAL SITUATIONS 
Renal insufficiency: 
The half life of gabapentin is increased in patients with reduced 
creatinine clearance. Hence dose adjustment is necessary. 
HEMODIALYSIS 
In patients on dialysis, the half life of gabapentin is reduced. 
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HEPATIC DISEASE 
Since Gabapentin is not metabolic not study was performed is 
patients with hepatic impairment. 
 
AGE 
With increasing age, renal clearance decreases. Hence reduction of 
dose is required in patients who have age related decline in renal 
function. 
GENDER 
Pharmacokinetic parameters for male and female are similar and 
hence there is no significant gender differences. 
Pregnancy & lactations 
Gabapentin has been assigned to pregnancy category C. Animal 
studies have revealed fetotoxicity involving delayed ossification of 
several bones. There is no controlled data in human pregnancy. 
Gabapentin should be given when benefit outweighs risk. 
Gatapentin is secreted into human milk, hence used only when 
benefit outweight the risk. 
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ANTI-NOCICEPTIVE MECHANISM 
Exact mechanism is not known. Proposed mechanisms are 
The most likely antinociceptive target of gabapentin is voltage 
gated calcium channels which are upregulated in the dorsal root 
ganglia and spinal cord after surgical trauma. 
Galapentin selectively binds to α2δ subunit of voltage gated calcium 
channels and inhibits calcium influx through these channels. 
Thereby inhibiting the release of excitatory neurotransmitters (eg 
glutamate, aspartate, substance P, calcitonin gene related peptide) 
from the primary afferent nerve fibres in pain pathway. 
Gatapentin does not affect the nociceptive threshold. It has 
antiallodynic and antihyperalgesic properties. 
Gabapentin activates the descending nor adrenergic system and 
produces spinal nor epinephrine release, which acts on spinal α2 
adrenoreceptor to produce analgesia. 
PERIOPERATIVE BENEFITS OF GABAPENTIN 
ADMINISTRATION 
All perioperative applications are “off label” uses 
Perioperative anxiolysis 
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Post operative analgesia 
Attenuation of haemodynamic response to laryngoscopy and 
intubation 
Prevents chronic post surgical pain, postoperative nausea, vomiting 
and delirium. 
ADVERSE EFFECTS 
Sedation and dizziness are most common. 
Others: Asthesia, headache, nausea, ataxia, weight gain and 
amblyopia. 
 
. 
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Review of Literature 
 
1. C. Menigaux et al conducted a study to find out whether 
Gabapentin when given oral preoperatively has effect on post-
operative pain intensity and analgesic requirement. This study was 
done on patients who underwent arthroscopic procedure. Patients 
satisfying the inclusion criteria were divided into Gabapentin and 
Placebo groups and were given Gabapentin 15mg/Kg and Placebo 
capsules orally One hour before the surgery. A standard anesthetic 
technique was followed. At the end of surgery patients were given 
Morphine 1mg/Kg and Ketoprofen for pain relief. They found that 
pain scores during rest and movement and analgesic requirement 
were lower in gabapentin group and there were no increased 
incidence of side effects. 
 
2. Vanags et al conducted a study in patients undergoing abdominal 
hysterectomy regarding the use of pre-operative Gabapentin on 
post-operative pain and analgesic requirements. Study patients 
were divided into Group G and Group P to receive oral 
Gabapentin 1200mg and placebo capsules Two hours before 
surgery. A standard technique of anesthesia was used for all 
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patients. Post-operative analgesia was provided with Fentanyl 
infusion of 40µg/hr and 20µg Bolus dose was given on demand 
with 15 minutes lockout interval. Post-operative pain intensity and 
requirement of Fentanyl were considerably low in group G 
patients during first 24 Hours of post-operative period. 
 
3. O. Kiskira et al conducted a study in Patients undergoing 
orthopedic procedures to assess the usefulness of pre-operative 
administration of Gabapentin on post-operative pain intensity and 
requirement of analgesic. Patients were divided into Group G and 
Group P randomly. They were given Gabapentin 800mg and 
Placebo capsules one hour before surgery. At the end of surgery, 
patients were started on Morphine infusion 2mg/hr and Bolus dose 
of 1mg was given on demand for pain control. During first 24 
hours of post-operative period, they were monitored for pain 
scores by visual analogue scale, total Morphine required and side 
effects.It was found that VAS scores and Morphine requirement 
was lesser  in Group G patients. 
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4. C. K. Pandey et al conducted a study to find out the effectiveness 
of preoperative Gabapentin in controlling post-operative pain and 
analgesic requirement. Study was performed in patients 
undergoing Lumbar discectomy. They were divided into Group G 
who received gabapentin 300mg and Group P were given Placebo 
capsules before 2 hours of surgery. Fentanyl was given at a dose of 
2mg/Kg on demand intravenously for effective control of post-
operative pain. Patients were monitored post-operatively for pain 
scores up to 24 hours. They found that patients in Group G showed 
significantly lower pain scores and reduced requirement for 
Fentanyl in the postoperative period. 
 
5. Rachael K. Seib et al conducted a study to evaluate the efficacy of 
Gabapentin in controlling postoperative pain. Eight studies were 
selected  by them and analyzed for post-operative pain scores, total 
analgesic dosage required and the incidence of side effects. They 
concluded that the pain scores and the need for analgesic were 
lower in patients who received Gabapentin preoperatively. 
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6. Hussain Al-mujadi et al conducted a study in patients undergoing 
Thyroidectomy. Patients were divided into two groups – Group G 
and Group P. They were administered Gabapentin 1200mg and 
Placebo capsules two hours before surgery. Patients were 
monitored for VAS score during rest and movement, dosage of 
Morphine required and the occurrence of side effects. All patients 
were given 3mg of Morphine intravenously on demand until the 
VAS scores reached 4 at rest and 6 at movement. They found that 
VAS scores at rest and movement were lower and there was 
reduction in the dosage of Morphine used to treat post-operative 
pain. They also found that side effects were not significant 
between these two groups. 
 
7. Nagwa M. Doha et al conducted a study to evaluate the efficacy of 
Gabapentin in reducing the intra-operative and post-operative need 
for analgesics in patients undergoing Mastectomy. They were 
divided into two groups and Group G received 1200mg 
Gabapentin and Control group received Placebo capsules two 
hours before surgery. Intra-operative need for anesthetic agent and 
analgesic to maintain adequate depth of anesthesia was recorded in 
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both groups which showed that the anesthetic and analgesic need 
was lower in patients who received Gabapentin. Post-operatively  
the pain intensity score and analgesic dosage required were 
recorded which was significantly lower  in Group G patients. It 
was also found that the incidence of dizziness was higher in Group 
G patients. 
 
8. Turan et al  conducted a study to find out whether preoperative 
administration of Gabapentin has a role in reducing the VAS 
scores and Tramadol requirement in patients undergoing 
hysterectomy through abdominal approach. Anesthesia was 
conducted in a standard manner. Post-operatively, all patients were 
given Tramadol for control of post-operative pain in a standard 
manner. All of them were monitored for total dosage of analgesic 
required and for their pain intensity scores. It was found that the 
Tramadol consumption and VAS scores were lower in Group G 
patients. 
 
9. Elina M. Tiippana et al selected 22 case studies regarding the pre-
operative administration of Gabapentin. Outcome of these studies 
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were analyzed. They found that one dose of Gabapentin ranging 
from 300-1200mg when given pre-operatively produced 20% to 
60% of Opioid sparing effect. They also found that the dose of 
Gabapentin used did not have any effect on Opioid consumption in 
the post-operative period. Their outcome revealed that the adverse 
effects of Opioids were significantly reduced by administration of 
Gabapentin per-operatively. Their studies revealed that sedation 
and dizziness were the most common side effects associated with 
use of Gabapentin. 
 
10. C. K. Pandey et al did a study in patients undergoing 
Laparoscopic Cholecystectomy. The study patients were divided 
into three groups to receive Gabapentin 300mg or Tramadol 
100mg or Placebo Two hours before surgery. Postoperatively all 
patients were assessed regarding their pain scores and analgesic 
requirements. They found that VAS scores and dosage of 
analgesic required was significantly lower in patients who 
received Gabapentin compared to Tramadol or Placebo group of 
patients. It was also found that sedation, nausea and vomiting were 
the side effects commonly recorded with Gabapentin use and 
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respiratory depression was commonly seen in patients who 
received Tramadol. 
 
11. Dilek Memis et al conducted a study in patients undergoing 
endoscopic sinus surgery under local anesthesia. Patients were 
randomly allocated to receive Gabapentin 1200mg or Placebo Two 
hours before surgery. Diclofenac  and Fentanyl was used to control 
intraoperative and postoperative pain. Sedation and pain intensity 
was assessed intraoperatively and postoperatively. It was found 
that Gabapentin group of patients had lower scores and analgesic 
requirement. They also found that dizziness is a common side 
effect of Gabapentin which limits its use in Ambulatory surgery. 
They found that time for first rescue analgesic was longer in 
Gabapentin group. 
 
12. Anil Verma et al conducted a study in patients undergoing 
abdominal hysterectomy under combined spinal epidural 
anesthesia. Patients were divided into two groups and were given 
Gabapentin 300mg or Placebo Two hours before surgery. Post-
operatively analgesia was provided with 0.125% Bupivacaine 
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epidurally on demand. The pain scores and number of epidural 
Boluses received were recorded for all patients. It was found that 
the Gabapentin group had lower VAS scores and less number of 
epidural Boluses to control post-operative pain. 
 
13. Fassoulaki et al conducted a study to find out whether Gabapentin 
could reduce the hemodynamic response to laryngoscopy and 
intubation. Patients were divided to receive Gabapentin 1600mg 
every Six hours from a day before surgery. Hemodynamics were 
monitored before and after the administration of anesthetic and 
after Intubation. It was found that Gabapentin reduces the 
hypertensive response but  has no effect on heart rate response 
during intubation and Laryngoscopy. 
 
14. Ken-ichiro et al conducted a study to evaluate whether 
Gabapentin has any action on spinal noradrenergic neurons 
whether it modulates Hyperalgesia associated with surgery. 
Gabapentin was given to rats and an incision was made in hind 
paw. Withdrawal threshold to pressure on paws is recorded. It was 
found that Gabapentin acts on descending spinal nor adrenergic 
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neurons to release noradrenaline which acts on α2 receptors in 
spinal cord to produce analgesia. 
 
15. Jesper Dirks et al conducted a study in patients undergoing 
mastectomy to evaluate the effectiveness of Gabapentin on post-
operative pain. Patients were divided into two groups to receive 
Gabapentin 1200mg or Placebo One hour before surgery. A 
standard technique of anesthesia was practiced. Postoperatively 
the pain intensity score and analgesic requirement was recorded 
for all patients. It was found that pain scores with movement were 
significantly lower at 2nd and 4th post-operative hours in patients 
who received Gabapentin. There was no difference in pain at rest 
and side effects between these groups. 
 
16. Karin L. Peterson et al conducted an analytic study to establish 
the effectiveness of Gabapentin in reducing the acute pain and 
inhibiting cutaneous Hyperalgesia. They analyzed the data 
obtained from studies involving role of Gabapentin in animal 
models and clinical trials. They found that Gabapentin is useful in 
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acute pain conditions like post-operative pain and is also useful in 
chronic pain syndromes. 
 
17. Panah Khahi et al conducted a study in patients undergoing 
orthopedic procedures involving tibia under spinal anesthesia. 
Patients were divided into two groups. Groups G received 
Gabapentin 300mg and Group P received Placebo capsules orally 
two hours before surgery. All patients were monitored post-
operatively for VAS scores and analgesic requirement upto 24 
Hours. It was found that VAS scores were less in Group G patients 
at Two hours post-operatively. There was no significant difference 
in VAS scores at all other time intervals between Group G and 
Group P. They also found that Gabapentin did not produce any 
side effect at this dosage. 
 
18. Montazeri et al conducted a study in patients undergoing 
orthopedic procedures for lower limb under General anesthesia. 
Patients satisfying their inclusion criteria were divided randomly 
into two groups. Group G was given Gabapentin 300mg and 
Group P received Placebo capsules Two hours before surgery. 
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Postoperatively pain control was achieved with Morphine 
0.05mg/Kg intravenously. All patients were observed for post-
operative pain scores and total dosage of Morphine required for 24 
hours. They found that patients who received Gabapentin had 
significantly lower VAS scores at all-time intervals when 
compared to Placebo group. It was also found that total Morphine 
required to control post-operative pain was lower in Gabapentin 
group. 
 
19. A.Turan et al conducted a study in patients undergoing hand 
surgery under intravenous Regional anesthesia. Patients were 
divided into Group G and Group P to receive Gabapentin 1200mg 
and Placebo capsules one hour before surgery. The parameters 
observed by them intra-operatively were the onset of sensory 
blockade, motor blockade, intensity of Tourniquet pain and time 
for requirement of first analgesic dose and quality of anesthesia. 
Post-operatively all patients were monitored for pain scores, 
analgesic requirement and time for rescue analgesic after surgery. 
They found that intra-operatively there was no difference in the 
onset of sensory and motor blockade but the intensity of 
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Tourniquet pain was lower in Group G and there was significant 
prolongation in the time for rescue analgesic requirement intra-
operatively. Quality of Anesthesia was found to be better in Group 
G. They also found that the VAS scores and analgesic 
consumption was lower in Group G in the post-operative period. 
Time for requirement of rescue analgesic was significantly longer 
in Group G patients post-operatively.  
 
 
46 
 
MATERIALS AND METHODS 
This  is a prospective, randomized, single blinded case controlled 
study.This study was conducted in patients who underwent elective 
abdominal hysterectomy at Institute of Obstetrics and Gynaecology, 
Madras Medical College. Institutional Ethical Committee clearance 
was obtained.  
INCLUSION CRITERIA 
• American Society of anaesthesiologists physical status I and 
II patients 
• Age group of 20-60 years  
• Patients posted for elective abdominal hysterectomy  
• Patients given informed written consent 
EXCLUSION CRITERIA 
• Patients not satisfying inclusion criteria  
• Known sensitivity to gabapentin   
• History of seizure disorder 
• History of Gabapentin consumption,  
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• Known psychiatric disorder,  
• Chronic pain syndromes, 
• Liver or renal disease, 
• history of drug abuse, 
• Recent intake of analgesics in past 24 hours were excluded 
from the study. 
Patients satisfying inclusion criteria were randomly allocated by 
closed envelope method into two groups: Group G(gabapentin 
group) and Group P(placebo group). They were informed 
preoperatively about the visual analogue scale. 
Patients in Group G received Gabapentin 300mg orally and Group P 
patients received placebo capsules with sips of water two hours 
before surgery. All patients were premedicated with Inj.Ranitidine 
5omg and metoclopramide 10mg intravenously one hour before 
surgery. 
Inside the operating room, monitors (ECG, NIBP, Pulse oximetry) 
were connected. Bladder was catheterized to monitor urine output. 
Intravenous access established with 18G cannula. 
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All patients were preloaded with 10ml/kg of Ringer’s locate 
solution. Under strict aseptic precautions, 4ml of hyperbaric 
solution of 0.5% bupivacaine given in lumbar subarachnoid space. 
After confirming adequate height of blockade, patients are sedated 
with 1 to 2mg of midazolam intravenously. 
At the end of surgery, patients were shifted to ward. VAS scores 
were assessed at rest and during movement in the immediate 
postoperative period (0hr) and at 1, 2, 4, 6, 12 and 24 hours post 
operatively. Patients were given Inj.Tramadol 2mg/kg 
intravenously when the VAS score was 4 or greater. Subsequently 
Inj.tramadol of 1mg/kg IV was given every 15 minutes until VAS 
score was less than 4. Dosage not to exceed 250mg at one time and 
600mg per day.  Time since spinal anaesthesia to first requirement 
of  analgesic (T), Total analgesic requirement in first 24 hours, 
VAS scores at rest and movement, ramsay sedation score, side 
effects of the drug like Somnolene, dizziness, confusion, nausea, 
vomiting were recorded in first 24 hours postoperatively. 
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      RAMSAY SEDATION SCORE: 
       1 – Anxious, Agitated, or restless 
       2 – Cooperative, oriented and Tranquil 
       3 – Responds to command    
       4 –Asleep but has a brisk response to light glabellar tap or loud 
auditory stimulus 
      5 – Asleep but has a sluggish response to light glabellar tap or 
loud auditory stimulus 
      6 – Asleep, no response.    
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                             OBSERVATION & RESULTS 
This is a prospective, randomized, single blinded, case controlled 
study to assess the effectiveness of preoperative administration of 
gabapentin on postoperative pain intensity and analgesic 
requirement. Sixty patients satisfying the inclusion criteria were 
randomly allocated into gabapentin group (group G) and placebo 
group (group P). 
At the end of study the data collected was analysed using statistical 
software package SPSS 16.0 . Quantitative data was analysed using 
students t-test and qualitative data was analysed using chi-square 
test. The results are expressed in terms of mean and standard 
deviation.  P value of less than 0.05 is considered to be statistically 
significant. 
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Table 1:AGE  
                 Age Distribution of the Study Sample  
 
Age  
Group 
(in 
Years) 
GROUP-G GROUP-P TOTAL 
Number Percentage Number Percentage Number Percentage 
30-35 2   6.70 2   6.70 4   6.70 
35-40 3 10.00 4 13.30 7 11.70 
40-45 9 30.00 7 23.30 16 26.70 
45-50 11 36.70 10 33.30 21 35.00 
50-55 5 16.70 7 23.30 12 20.00 
Mean±sd 46.40 ± 5.26 46.80 ± 5.50 46.60 ± 5.34 
t-value 0.29   
Df 58   
p-value 0.77 (Not Significant)   
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Patients enrolled in the study were found to be in the age group 
range of 33 to 55 years. Patients in group G were in the mean age 
group of 46.40 with standard deviation of 5.26. Patients in Group P 
were found to have a mean age group of 46.80 with a standard 
deviation of 5.50. The P value was found to be 0.77, which is not 
significant. This implies that there is no difference in age between 
the groups and are comparable. 
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Table 2: WEIGHT 
 
Weight 
 (in Kgs) 
GROUP-G GROUP-P TOTAL 
Number Percentage Number Percentage Number Percentage 
45-50 2 6.70 4 13.30 6 10.00 
50-55 7 23.30 7 23.30 14 23.30 
55-60 11 36.70 13 43.30 24 40.00 
60-65 8 26.70 5 16.70 13 21.70 
65-70 2 6.70 1 3.30 3 5.00 
Mean±sd 58.40 ± 5.16 56.83 ± 4.74 46.40 ± 5.34 
t-value 1.23   
Df 58   
p-value 0.23 (Not Significant)   
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The mean weight of patients in group G was found to be 58.40 kg 
with a standard deviation of 5.16. Patients in group P were found to 
have a mean weight of 56.83Kg with a standard deviation of 4.74. 
The P value calculated was 0.23, which is not significant. This 
indicates that both groups are comparable in terms of weight. 
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Table 3: HEIGHT 
 
 Height 
 (in cms ) 
GROUP-G GROUP-P TOTAL 
Number Percentage Number Percentage Number Percentage 
145-150 4 13.30 4 13.30 4 13.30 
150-155 9 30.00 12 40.00 21 35.00 
155-160 12 40.00 10 33.30 22 36.70 
160-165 5 16.7 4 13.30 9 15.00 
Mean±sd 156.23 ± 3.93 155.70 ± 4.44 155.97 ± 4.166 
t-value 0.49   
Df 58   
p-value 0.62 (Not Sifnificant)   
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Group G patients had a mean height of 156.23 cm with a standard 
deviation of 3.93. Patients in group P were found to have a mean 
height of 155.70 cm with a standard deviation of 4.44. The P value 
was found to be 0.62, which is not significant. So both groups are 
comparable in terms of height. 
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Table 4: DIAGNOSIS 
The disease condition for which the patients in both groups were 
scheduled for abdominal hysterectomy are as follows: 
 
 
 
 
 
Diagnosis Group-G Group-P Total 
N % N % N % 
1 – fibroid 18 60.00 21 70.00 39 65.00 
2 – cervical polyp 3 10.00 3 10.00 6 10.00 
3 – DUB 3 10.00 3 10.00 6 10.00 
4 – PID 2   6.70 1   3.30 3   5.00 
5 – chronic cervicitis 3 10.00 1 3.30 4    6.70 
6 - endometriosis 1    
3.30 
1 
3.30 
2 
   3.30 
Chi-square value  1.56 
Df 5 
p-value 0.91 (Not Significant) 
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This data was analysed by chi-square test. The P value was found to 
be 0.91, which is not significant. Hence the diseased condition for 
which patients underwent surgery is also comparable between the 
groups. 
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Table 5: ASA PS Classification 
 Group-G Group-P 
Number Percentage Number Percentage 
ASA PS I 24 80.00 24 80.00 
ASA PS II 6 20.00 6 20.00 
Chi-square value 0.001 
df 1 
p-value 1.000 (Not Significant) 
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In both groups (Group G & Group P), 24 patients in each group 
belonged to ASA PS-I and 6 patients in each group belonged to 
ASA PS-II. The P value was found to be greater than 0.05, hence 
value is not significant. Therefore patients in both groups were 
comparable in terms of ASA PS classification. 
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Table 6: DURATION OF SURGERY 
Duration in  
minutes 
Group-G Group-P 
Mean 102.33 107.33 
Sd 14.72 12.30 
Range 70 - 130 80 - 130 
t-Value 1.43 
Df 58 
p-value 0.16  (Not Significant) 
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The mean duration of surgery in group G patients were found to be 
102.33 minutes with standard deviation of 14.72. Group P patients 
had a mean duration of surgery of 107.33 minutes with a standard 
deviation of 12.30. The P value was found to be 0.16, which is not 
significant. Hence there is no difference between groups with 
regard to duration of surgery. 
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Table 7: VAS Score at Rest 
Duration Group-G 
Mean ± sd 
Group-P 
Mean ± sd 
t-value Df=58 
 p-value 
0 hour 1.00 ± 0.00 1.00 ± 0.00 - - 
1 hour 3.50 ± 1.55 5.73 ± 1.74 5.25 0.000 
2 hours 3.67 ± 0.88 4.33 ± 0.66 3.31 0.002 
4 hours 3.13 ± 0.43 3.73 ± 0.69 4.03 0.000 
6 hours 2.90 ± 0.55 3.60 ± 0.78 4.06 0.000 
12 hours 2.27 ± 0.52 3.23 ± 0.50 7.31 0.000 
24 hours 1.67 ± 0.48 2.03 ± 0.49 2.93 0.01 
* Not Significant  
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         All patients were monitored for VAS scores at rest in the 
immediate postoperative period (0 hr), at 1, 2, 4, 6, 12, and 24 
hours postoperatively. In the immediate postoperative period (0 hr) 
VAS score at rest was found to be 1 in both Group G and Group P. 
This may be due to the effect of spinal anaesthesia.  The  mean 
VAS scores at rest during postoperative period of 1, 2, 4, 6, 12 and 
24 hours in group G patients were 3.50, 3.67, 3.13, 2.90, 2.27 and 
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1.67 respectively and in Group P patients the mean VAS scores 
were 5.73, 4.33, 3.73,  3.60, 3.23 and 2.03 respectively. The P 
value at all time intervals were less than 0.05. This shows that the 
mean VAS scores at rest were significantly lower  in group G 
compared to group P patients.    
 
 
 
 
Table 8: VAS Score with Movement 
 
Duration Group-G 
Mean ± sd 
Group-P 
Mean ± sd 
t-value Df=58 
 p-value 
0 hour 1.10 ± 0.31 1.47 ± 0.51 3.39 0.001 
1 hour 4.17 ± 1.98 6.73 ± 1.91 5.10 0.000 
2 hours 4.93 ± 0.98 5.50 ± 0.78 2.48 0.02 
4 hours 4.20 ± 0.48 4.77 ± 0.68 3.72 0.000 
6 hours 4.20 ± 0.49 4.76 ± 0.67 3.73 0.000 
12 hours 3.27 ± 0.52 4.30 ± 0.54 4.19 0.000 
24 hours 2.13 ± 0.43 2.57 ± 0.68 2.95 0.005 
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Patients in both groups were assessed for VAS scores with 
movement by making the patients to sit. The mean VAS scores with 
movement at 0, 1, 2, 4, 6, 12 and 24 hours of postoperative period 
in group G patients were 1.10, 4.17, 4.93, 4.20, 4.20, 3.27, 2.13 
respectively and in group P patients the mean scores were 1.47, 
6.73, 5.50, 4.77, 4.76, 4.30, 2.57 respectively. The P value at all 
time intervals were less than 0.05. This shows that the mean VAS 
scores with movement were significantly less in group G patients 
compared to group P at all time intervals. 
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Table 9: T1 Score 
T1 score is the time from spinal anaesthesia to requirement of first  
analgesic dose.  
Duration in 
minutes 
Group-G Group-P 
Mean 183.00 172.33 
Sd 19.81 11.50 
Range 150 - 225 155 - 200 
t-Value 2.55 
Df 58 
p-value 0.01  (Significant) 
68 
 
Postoperatively all patients were monitored for VAS scores 
periodically. When the VAS score at rest is 4 or greater, patients 
were given Tramadol 2mg/kg intravenously as initial dose. So T1 is 
the time interval between providing spinal anaesthesia and 
administration of first dose of tramadol. It was found that this Time 
interval  was 183.0minutes  in group G and 172.33minutes in group 
P. The P value was found to be 0.01, which is considered 
significant. This indicates that T1 score is significantly greater in 
group G compared to group P. 
 
69 
 
Table 10: Tramadol Consumption 
 
 Group-G Group-P 
Mean 232.33 285.83 
Sd 22.54 23.46 
Range 200 – 300 250 - 335 
t-Value 9.01 
Df 58 
p-value 0.000 (Significant) 
 
 
Postoperative analgesia was provided with intravenous tramadol for 
all patients. Initial dose of tramadol is 2mg/kg intravenously, when 
patients VAS score is 4 or more. Subsequently tramadol was given 
at a dose of 1mg/kg when the VAS score was 4 or more, or on 
patients demand. Care was taken not to exceed the limit of 
250mg/dose and 600mg/day. Total dosage of Tramadol required for 
each patient during postoperative period upto 24 hours was 
calculated. In group G patients, average dose of tramadol required 
was 232.33 mg and in group P, the dosage required was 285.83mg. 
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The P value was found to be 0.0001.. Hence it was found that total 
tramadol consumption was significantly lower in group G patients 
comparable to group P. 
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Table 11: Ramsay Sedation Score 
 
Duration Group-G 
Mean ± sd 
Group-P 
Mean ± sd 
t-value Df=58 
 p-value 
0 hour 2.93 ± 0.25  2.27 ± 0.45  7.07 0.000 
1 hour 2.37 ± 0.49  2.00 ± 0.00  4.10 0.000 
2 hours 2.30 ± 0.47  2.07 ± 0.25  2.41 0.02 
4 hours 2.23 ± 0.43  2.00 ± 0.00  2.97 0.004 
6 hours 2.33 ± 0.48  2.10 ± 0.31  2.45 0.03 
12 hours 2.57 ± 0.50  2.20 ± 0.41  3.10 0.003 
24 hours 2.37 ± 0.49 2.13 ± 0.35 2.13 0.04 
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Postoperatively all patients were assessed for the level of sedation 
using Ramsay sedation score periodically at 0, 1, 2, 4, 6, 12, and 24 
hours. The  mean sedation scores at 0, 1, 2, 4, 6, 12 and 24 hours of 
postoperative period were 2.93, 2.37, 2.30, 2.23, 2.33, 2.57 and 
2.37 respectively in group G and in group P the scores were 2.27, 
2.00, 2.07, 2.00, 2.10, 2.20 and  2.13 respectively. The P value at 
all time intervals was less than 0.05. This shows that the level of  
sedation was significantly higher in group G patients compared to 
group P. 
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Table 12: COMPLICATIONS 
 
Complications Group-G Group-P 
Number Percentage Number Percentage 
No Complication 24 80.00 24 80.00 
Nausea 3 10.00   4 13.30 
Vomiting 2   6.70   2   6.70 
Diziness 1   3.30   0 - 
Chi-square value 1.14 
df 3 
p-value 0.77  (Not Significant) 
              
       During the postoperative period, all patients were monitored 
for complications  periodically. In both the groups out of 30 
patients 24 patients did not develop any complications. Nausea was 
noted in 3 patients in group G and in 4 patients in group P. 
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Vomiting occurred in 2 patients in each group. Dizziness was found 
in 1 patient of group G and none developed dizziness in group P. 
The P value was found to be 0.77. This shows that there is no 
significant difference in the incidence of side effects between both 
groups.    
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                                 DISCUSSION 
Multimodal approach to control postoperative pain is considered as 
a best therapeutic option. Role of anticonvulsants in treatment of 
acute postoperative pain has been demonstrated by many clinical 
studies. This study was done to assess whether gabapentin given 
preoperatively has a role in reducing acute postoperative pain. 
          The results of my study shows that gabapentin 300mg given 
two hours before surgery significantly reduces postoperative pain 
scores, analgesic requirement, prolongs  the time for requirement of 
first analgesic dose without increasing the incidence of side effects 
except for sedation . 
            Gabapentin 300mg was given orally two hours  before 
surgery because after oral intake it reaches a peak plasma 
concentration by two to three hours. In a study by Welty et al7 it 
was found that the drug  readily crosses the blood brain barrier and 
its concentration in brain is nearly similar to that present in blood.  
so that at the time of surgical incision, gabapentin is at its peak 
concentration in plasma and in brain tissue, thereby it prevents 
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peripheral and central sensitization by reducing hyperalgesia and 
allodynia associated with surgical manipulation. 
              Gabapentin dosage of 300mg was selected for this study 
because its oral bioavailability is 60% and decreases with 
increasing dosage. Similar dose of 300mg was used in a study 
conducted by C.K.Pandey  et al
26
 in patients undergoing 
laparoscopic cholecystectomy and by Panah Khahi et al
10
 in 
patients undergoing orthopedic procedures under spinal 
anaesthesia.
 
 
                 In a study by Elina M. Tiippana et al31, it was found 
that one dose of gabapentin ranging from 300 – 1200mg when 
given preoperatively reduces opioid consumption by 20 – 60 %. 
They also found that the dose of gabapentin used did not have any 
effect on opioid consumption.  
                In this study, during the postoperative period it was 
found that the VAS scores at rest and movement  were significantly 
less(P Value <0.05) in gabapentin group compared to placebo group 
at 0, 1, 2, 4, 6, 12 and 24 hours. 
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              In a study by Dirks et al
21
 in patients undergoing 
mastectomy gabapentin was found to reduce the pain scores with 
movement but not at rest. Mean VAS scores with  rest in group P vs 
group  G at 2nd hour were 33mm vs 19mm (P value-0.094)  and at 
4 hours were 12mm vs 7mm (P value=0.084)  and was found as not 
significant. But VAS scores during movement in group P vs group 
G at 2
nd
 hour was 41mm vs 22mm (P value<0.0001) and at 4
th
 hour 
was 31mm vs 9mm(P value=0.018) and was found to be significant. 
           In a study conducted by A.Turan et al
1
 in patients 
undergoing abdominal hysterectomy, gabapentin produced a 
significantly lower VAS scores both during rest and movement at 1, 
4, 8, 12, 16, 20 and 24 hours.              
            According to study conducted by Dahl et al9, gabapentin is 
considered as a useful drug in perioperative period.  
              According to a study by Gee N.S. et al
44
, analgesic action 
of gabapentin is found to be mediated by its binding to α 2δ subunit 
of voltage gated calcium channels in dorsal horn of spinal cord, 
which are upregulated during noxious stimuli. 
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             According to a study conducted by Hurley et al
24
, binding 
of gabapentin to calcium channel results in reduced calcium influx 
thereby reducing release of excitatory aminoacids involved in 
nociception. 
              In our study, the mean  total tramadol consumption was 
found to be significantly lower in gabapentin group. The 
requirement of tramadol in 24 hour period was found to be 
232.33mg in group G and 285.83mg in group P with P value of 
0.0001. In  a study by C.K.Pandey et al
26
  in patients undergoing 
laparoscopic cholecystectomy the fentanyl consumption was found 
to be significantly lower in gabapentin group (221µg) than placebo 
group(355µg) with P value <0.05. 
             In a study conducted byA.Turan et al1, gabapentin was 
found to reduce tramadol consumption at 12, 16, 20, 24 hours and 
the total tramadol requirement in patients undergoing abdominal 
hysterectomy. 
        In a study by Hussain Al-mujadi et al
4 
, in patients undergoing 
thyroidectomy, morphine requirement was 15.2mg in gabapentin group 
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patients while in placebo group patients it was 29.5mg( with p valve 
<0.05) 
             According to a study conducted by Mc Lean et al
14
, use of 
gabapentin is associated with side effects like nausea, vomiting, 
sedation, dizziness, confusion, headache, ataxia and weight gain. 
            In this study the incidence of side effects like nausea and 
vomiting was less in both placebo and gabapentin group and also 
there was no statistically significant difference between them.only 
one patient in group G developed dizziness which was not 
statistically significant . This finding is similar to a study 
conducted by Dirks et al
21
. In a study by C K Pandey et al
2
 in 
patients undergoing discectomy , it was found that incidence of side 
effects like nausea (5 vs 4) , vomiting (3vs 4) , fatigue (1 vs 0) and 
dizziness (1vs 0) were found to be similar in group G and group P .
 
           Sedation scores in this study at 0 , 1 , 2 ,4 , 6 , 12 and 24 hrs  
were higher in group G compared to group P .In a study by C K 
Pandey et al
26   
in patients undergoing laproscopic cholecystectomy 
, it was found that there was higher incidence of sedation ( 33.98%) 
in gabapentin group of patients.        
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 In this study it was found that the time to requirement of first 
rescue analgesia is prolonged in gabapentin group of patients. This 
finding is supported by studies conducted by Dilek Memis
31
 et al in 
patients undergoing endoscopic sinus surgery.In his study the time 
to first analgesic requirement was longer in gabapentin group( 18± 
9 hrs ) than placebo group ( 9± 7 hrs ) with p value of < 0.001. 
          In a study by A.Turan et al
19
 it was found that in patients 
undergoing hand surgery under IVRA, there was significant 
prolongation in the time for rescue analgesic requirement both 
intraoperatively and postoperatively.   
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                           SUMMARY  
         This is a prospective, randomised, single blinded, case 
controlled study to evaluate the usefulness of preoperative 
administration of gabapentin 300mg oral in reducing postoperative 
pain and analgesic requirement. 
          By giving gabapentin 2 hours preoperatively, it reaches peak 
plasma concentration at the time of onset of surgical stimuli 
thereby inhibiting central and peripheral neuronal sensitization to 
pain. By preventing the initiation of noxious input it reduces 
postoperative pain intensity and analgesic requirement    
              Sixty patients satisfying the inclusion criteria were 
randomly divided into two groups of thirty each. Group G received 
gabapentin and group P received placebo capsules 2 hours before 
surgery. Postoperatively patients were monitored for pain scores by 
VAS scale, total analgesic requirement, and side effects upto 24 
hours. The data obtained was analysed. 
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Observations of the study are 
• Reduction in postoperative pain scores both at rest and during 
movement at  all time intervals of 0, 1, 2, 4, 6, 12 and 24 hours 
postoperatively in group G patients, 
• Reduction in total tramadol consumption during initial 24 
hours of postoperative period in group G patients, 
• Prolongation of the time to first  analgesic requirement in 
group G patients, 
• Sedation scores were higher in group G patients but is well 
tolerated, 
•  the incidence of other side effects like nausea , vomiting  , 
dizziness were found to be less in both the groups and were found 
to be statistically not significant . 
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                                CONCLUSION   
          This study demonstrates that a single oral dose of gabapentin 
300mg when given preoperatively reduces the postoperative pain 
scores and total tramadol consumption in patients undergoing 
abdominal hysterectomy under spinal anaesthesia. Sedation  was 
the only significant side effect observed with the gabapentin usage. 
.The incidence of other side effects like nausea , vomiting  , 
dizziness were found to be less in both the groups and were found 
to be statistically not significant Thus gabapentin can be considered 
as an adjunct in treating postoperative pain. 
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1 43 55 156 1 1 G 100 1 2 5 3 3 2 1 1 2 6 4 4 3 1 3 3 2 3 3 3 3 190 210 A A A 
2 48 62 153 3 1 G 80 1 2 4 3 3 2 2 1 2 5 4 4 3 2 3 3 2 3 3 3 3 200 240 A A A 
3 35 51 154 6 1 G 90 1 2 6 4 3 2 2 1 2 7 5 4 3 2 3 3 2 2 3 3 2 210 200 A A P 
4 45 65 161 1 2 G 130 1 6 4 3 3 3 1 2 7 6 4 4 4 2 2 2 2 3 3 2 3 190 250 A A A 
5 41 60 148 2 1 G 70 1 2 2 4 3 4 2 1 2 4 5 5 5 2 3 3 3 2 3 2 2 210 210 A P A 
6 44 57 158 1 1 G 110 1 5 3 3 4 3 2 1 6 4 4 5 4 2 3 2 3 3 2 3 2 170 230 A A A 
7 50 54 155 1 1 G 120 1 6 4 3 3 3 2 2 7 5 5 4 4 3 3 2 2 3 2 2 2 180 220 A A A 
8 47 58 163 5 1 G 95 1 2 5 3 3 2 1 1 2 6 4 4 3 2 3 3 2 3 3 3 3 205 240 A A A 
9 40 60 157 1 1 G 100 1 2 5 4 3 3 2 1 3 6 5 4 4 2 3 2 2 2 2 2 2 220 240 P A A 
10 46 63 150 1 2 G 105 1 2 5 3 3 3 1 1 2 6 4 4 4 2 3 3 2 2 2 2 3 225 240 A A A 
11 47 70 162 1 1 G 110 1 7 4 3 3 3 2 2 8 6 4 4 4 2 2 2 2 2 2 3 3 160 260 A A A 
12 53 56 155 1 1 G 105 1 4 3 3 2 2 2 1 5 4 4 3 3 3 3 2 3 3 3 3 2 165 220 A A A 
13 45 61 157 5 2 G 95 1 2 4 4 2 2 2 1 2 5 5 3 3 2 3 2 2 2 3 3 2 185 240 A A A 
14 48 58 160 1 1 G 100 1 4 3 3 3 2 2 1 5 4 4 4 3 3 3 2 2 2 2 3 2 160 230 A A A 
15 42 49 150 3 1 G 120 1 5 3 3 4 2 1 1 7 5 4 5 3 2 3 2 2 2 2 2 3 180 200 A A A 
16 40 64 158 1 1 G 130 1 4 3 3 2 2 2 1 5 4 4 3 3 2 3 2 3 2 3 3 2 150 300 A A A 
17 38 54 155 4 1 G 115 1 5 3 3 3 2 2 1 6 4 4 4 3 2 3 2 3 2 2 3 2 175 220 A A A 
18 43 59 161 1 1 G 95 1 2 4 3 3 2 1 1 2 7 4 4 3 2 3 3 2 2 2 3 3 195 240 P A A 
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19 46 57 157 1 1 G 90 1 2 4 3 3 2 2 1 2 6 4 4 3 2 3 3 2 2 2 2 3 190 220 A A A 
20 54 63 160 2 2 G 80 1 2 4 3 3 2 2 1 2 5 4 4 3 2 3 3 2 2 3 3 2 200 260 A A A 
21 48 59 162 1 1 G 110 1 5 3 3 3 2 2 1 6 4 4 4 3 3 3 2 2 2 2 2 2 170 240 A A A 
22 55 66 158 2 2 G 90 1 3 4 3 3 2 2 1 4 5 4 4 3 2 3 2 2 2 2 3 2 165 260 A A A 
23 45 62 153 3 1 G 105 1 4 3 3 2 2 1 1 5 4 4 3 3 2 3 2 3 2 2 2 3 165 240 A P A 
24 53 60 155 5 1 G 115 1 5 3 4 3 2 2 1 6 5 5 4 3 3 3 2 2 2 2 3 2 175 240 A A A 
25 58 64 156 1 1 G 100 1 2 3 3 3 2 2 1 3 4 4 4 3 2 3 3 2 2 2 2 2 190 260 P A A 
26 47 55 158 4 1 G 95 1 3 3 3 4 2 2 1 4 4 4 5 3 2 3 2 3 2 2 2 2 155 220 A A A 
27 53 48 152 1 2 G 80 1 2 4 3 3 2 1 1 2 5 5 4 3 2 3 3 2 2 2 2 3 200 200 A A A 
28 49 52 150 1 1 G 105 1 4 3 2 2 2 2 1 5 4 3 3 3 2 3 2 2 2 2 3 2 160 200 A A A 
29 46 54 154 1 1 G 120 1 5 3 3 3 2 1 1 6 4 4 4 3 2 3 2 3 2 2 2 2 180 220 A A A 
30 43 56 159 1 1 G 110 1 4 3 3 2 2 1 1 5 4 4 3 3 2 3 2 3 2 2 3 3 170 220 A A A 
31 48 55 158 1 1 P 110 1 7 4 3 3 4 2 1 8 5 4 4 5 2 2 2 2 2 2 3 2 170 275 A A A 
32 51 61 155 1 1 P 95 1 6 4 5 3 3 1 2 7 6 6 4 4 2 2 2 2 2 3 2 3 155 300 A A A 
33 45 59 164 4 1 P 115 1 6 4 3 3 2 2 1 7 5 4 4 3 3 2 2 2 2 2 2 2 175 300 P A A 
34 54 63 159 1 2 P 130 1 8 5 3 4 3 3 2 9 6 4 5 4 4 2 2 2 2 2 3 3 180 325 A P A 
35 37 58 163 6 1 P 100 1 6 4 3 3 3 2 1 7 5 4 4 4 3 3 2 2 2 2 2 2 160 300 A A A 
36 42 57 147 1 1 P 90 1 2 5 4 3 4 2 1 2 7 5 4 5 2 2 2 2 2 2 2 2 190 285 A A A 
37 49 52 153 2 1 P 105 1 6 4 5 4 3 2 2 7 5 6 5 5 3 2 2 2 2 2 2 2 165 250 A A A 
38 40 48 158 3 1 P 80 1 2 6 4 5 3 1 1 2 7 5 6 4 2 3 2 2 2 2 3 2 200 250 A A A 
39 48 50 154 1 1 P 110 1 7 5 4 3 3 1 2 8 6 5 4 4 2 2 2 2 2 3 2 3 170 250 A A A 
40 53 56 152 1 1 P 100 1 5 4 4 3 4 2 1 7 5 5 4 5 3 2 2 2 2 2 2 2 160 275 P A A 
41 33 58 154 3 1 P 95 1 2 4 3 4 3 3 1 4 6 4 5 4 3 3 2 2 2 2 2 2 190 290 A A A 
42 45 60 158 5 1 P 120 1 7 4 4 3 3 2 2 8 5 5 4 4 2 2 2 2 2 2 2 2 180 300 A A A 
43 48 54 162 1 2 P 105 1 6 4 3 4 3 2 1 7 5 4 5 4 2 2 2 2 2 2 3 2 165 270 A A A 
44 55 61 159 1 2 P 90 1 2 4 3 4 3 2 1 2 6 5 5 4 3 3 2 2 2 2 2 3 185 300 A P A 
45 52 59 155 1 1 P 115 1 7 5 4 5 3 2 2 8 5 5 6 4 2 2 2 2 2 2 2 2 175 300 A A A 
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46 49 48 150 2 1 P 110 1 7 5 4 3 3 2 2 8 6 5 5 4 3 2 2 2 2 2 2 2 170 250 A A A 
47 50 54 148 1 1 P 100 1 5 4 3 3 4 2 1 6 5 4 4 5 2 2 2 2 2 2 2 2 160 275 A A A 
48 47 58 151 1 1 P 110 1 6 4 5 3 4 2 2 7 5 6 4 5 3 2 2 2 2 3 2 2 170 290 A A A 
49 44 57 157 1 1 P 125 1 7 5 4 3 4 2 2 8 6 5 4 5 2 2 2 2 2 2 2 2 185 285 A A A 
50 40 62 160 3 1 P 95 1 5 4 4 5 3 2 1 6 5 5 6 5 2 2 2 2 2 2 2 2 155 310 A A A 
51 51 60 163 1 1 P 110 1 6 4 5 3 3 2 2 7 6 6 5 4 3 2 2 2 2 2 3 2 170 300 A A A 
52 47 55 158 1 2 P 115 1 6 4 4 3 4 2 2 7 5 5 4 5 2 2 2 2 2 2 2 2 175 275 A A A 
53 43 49 153 1 1 P 95 1 4 3 3 4 3 2 1 5 4 4 5 4 3 3 2 3 2 2 2 2 155 250 P A A 
54 49 58 150 1 1 P 105 1 7 5 3 4 3 2 1 8 6 4 5 4 2 3 2 2 2 2 2 2 165 300 A A A 
55 53 54 155 1 2 P 120 1 7 5 4 5 3 3 2 8 7 5 6 4 4 2 2 2 2 2 2 2 180 275 A A A 
56 45 65 159 1 1 P 110 1 7 5 4 3 3 2 1 8 6 5 4 4 2 2 2 2 2 2 3 2 170 325 A A A 
57 42 56 151 2 1 P 125 1 8 5 4 3 3 2 2 9 6 5 4 4 3 2 2 2 2 2 2 2 185 275 A A A 
58 56 59 156 1 2 P 110 1 7 4 4 5 3 2 1 8 5 5 6 4 2 3 2 2 2 2 2 2 170 300 A A A 
59 48 67 154 1 1 P 130 1 6 4 3 3 4 3 2 7 5 4 4 5 4 2 2 2 2 2 2 2 180 335 P A A 
60 40 52 155 1 1 P 100 1 5 3 3 4 3 2 1 7 4 4 5 4 2 3 2 3 2 2 2 2 160 260 A A A 
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PROFOMA 
 
Name           :                                                 IP NO    : 
Age              :                                                 weight    : 
Diagnosis     :                                                  height    :   
Procedure     :                                                  date       :  
ASA  PS       :                                                  group     : 
 
Preoperative history  
   Comorbid illness      : 
   Allergic H/O            : 
   Medication H/O       : 
 
Premedication  
   Gabapentin          :       yes/no          time :  
   Ranitidine            :     yes/no          time  : 
   Metoclopramide   :     yes/no          time  : 
 
Intraoperative period  
 
   Sub arachnoid block time    : 
   Skin incision time                  : 
   Skin closure time                  : 
96 
 
   
       Post operative period  
 
    
Time  (hrs) 
       VAS score Ramsay 
sedation    
score 
 
Tramadol 
dose      Rest Movement  
     0     
     1     
     2     
     4     
     6     
     12      
     24     
 
 
Adverse effects  
  Nausea /  vomiting  /  dizziness /  others 
 
Duration of surgery ( min )       : 
Time since spinal to requirement of first analgesic dose ( min ) : 
Total tramadol consumption ( mg )  : 
 
